Related Experiment Video
Updated: Jul 12, 2026
04:23
A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
QTc interval prolongation in pediatric eating disorder population.
Emily Kacer1, Erin Burnley1, Terrel Marshall1
1Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Frontiers in Pediatrics
|July 11, 2026
Summary
Pediatric eating disorders can cause QTc prolongation, a heart rhythm issue. This study found that QTc-prolonging medications and low electrolytes are linked to longer QTc intervals in these patients.
Area of Science:
- Pediatric Cardiology
- Clinical Nutrition
- Pharmacology
Background:
- Eating disorders in children and adolescents are linked to serious cardiac complications.
- QTc prolongation, a marker of delayed ventricular repolarization, can lead to fatal arrhythmias.
- Emerging evidence suggests extrinsic factors, not just the disorder itself, may contribute to QTc prolongation.
Purpose of the Study:
- To investigate the association between QTc interval prolongation and various factors in pediatric patients with eating disorders.
- To analyze demographic factors, electrocardiogram (ECG) findings, electrolyte levels, and medication use in relation to QTc prolongation.
Main Methods:
- Retrospective chart review of pediatric patients diagnosed with eating disorders at a tertiary children's hospital.
- Analysis of demographic data, ECGs for QTc interval measurement (Bazett calculation), serum electrolyte levels (calcium, magnesium, potassium), and records of QTc-prolonging medication use.
- Statistical analysis to determine associations between QTc prolongation and the evaluated factors.
Main Results:
- Out of 435 patients, 22 (approximately 5%) had prolonged QTc intervals (>460 ms).
- Significant differences in mean QTc values were observed across eating disorder subtypes, with bulimia nervosa and binge eating disorder showing the longest intervals.
- Patients on QTc-prolonging medications had significantly longer mean QTc intervals (p < 0.001).
- Inverse correlations were found between QTc length and serum calcium (p=0.0001), magnesium (p=0.01), and potassium (p=0.003).
Conclusions:
- QTc-prolonging medications and electrolyte abnormalities are associated with increased QTc interval length in pediatric patients with eating disorders.
- These factors represent potentially modifiable risk factors that warrant continuous monitoring and management.
- Further research is needed to fully elucidate the complex interplay between eating disorders, medications, electrolytes, and cardiac function.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:30Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
01:23Binge Eating Disorders
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...